Publication | Closed Access

A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer

NanomedicineDrug TargetingNanotherapeuticsEngineeringPolymer-drug ConjugateMedicinePharmaceutical NanotechnologyTargeted NanoplatformDrug Delivery SystemsMultidrug ResistanceBreast CancerTumor TargetingNano-drug DeliveryBiomedical EngineeringPharmacologyTumor Microenvironment